“This is a significant inconvenience and a potential problem for patients taking this medication because patients frequently require dosage modifications, typically dose reductions,” Dr. Hill said in an interview. “Having this new program in which the medication has to be exchanged for a single-tablet dose makes it much more difficult and onerous to make those changes.”
Feature
Physicians voice concern over ibrutinib flat pricing
